购物车
- 全部删除
- 您的购物车当前为空
FMF-04-159-2是一种高效的共价型细胞周期蛋白依赖性激酶14(CDK14)抑制剂,对CDK14和CDK2的IC₅₀分别为39.6 nM和256 nM。FMF-04-159-2能够减少α-突触核蛋白(α-Syn)在神经元中的聚集并在帕金森病模型中发挥作用,也能够通过减弱Wnt/β-catenin信号抑制三阴性乳腺癌(TNBC)的进展和转移。
为众多的药物研发团队赋能,
让新药发现更简单!
FMF-04-159-2是一种高效的共价型细胞周期蛋白依赖性激酶14(CDK14)抑制剂,对CDK14和CDK2的IC₅₀分别为39.6 nM和256 nM。FMF-04-159-2能够减少α-突触核蛋白(α-Syn)在神经元中的聚集并在帕金森病模型中发挥作用,也能够通过减弱Wnt/β-catenin信号抑制三阴性乳腺癌(TNBC)的进展和转移。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 468 | 现货 | |
5 mg | ¥ 788 | 现货 | |
10 mg | ¥ 1,380 | 现货 | |
25 mg | ¥ 2,980 | 现货 | |
50 mg | ¥ 4,470 | 现货 | |
100 mg | ¥ 6,700 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,180 | 现货 |
产品描述 | FMF-04-159-2 is a potent covalent cell cycle protein-dependent kinase 14 (CDK14) inhibitor with IC₅₀ of 39.6 nM for CDK14 and 256 nM for CDK2.FMF-04-159-2 is able to reduce α-synuclein (α-Syn ) aggregation in neurons and plays a role in Parkinson's disease models, and also inhibits triple-negative breast cancer (TNBC) progression and metastasis by attenuating Wnt/β-catenin signaling. |
靶点活性 | CDK14-CyclinY:39.6 nM (in NanoBRET assay) , CDK2:256 nM (in NanoBRET assay), CDK14-CyclinY:39.6 nM, CDK2:256 nM |
体外活性 | FMF-04-159-2 可以抑制 HCT116细胞增殖,IC50 为 1,144±190 nM。[1] |
分子量 | 683.01 |
分子式 | C28H30Cl3N7O5S |
CAS No. | 2364489-81-4 |
Smiles | N(C(=O)C1=C(Cl)C=C(Cl)C=C1Cl)C=2C(C(NC3CCN(S(=O)(=O)C4=CC(NC(/C=C/CN(C)C)=O)=CC=C4)CC3)=O)=NNC2 |
密度 | 1.53 g/cm3 (Predicted) |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 200 mg/mL (292.82 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
评论内容